Biopharmaceutical company Verastem Oncology has announced a new Phase 2 clinical trial for low-grade serous cancer (LGSOC). The trial will …
Cancer, Covid and Christmas
A Year of Change By Diane Evans-Wood Last year I wrote a blog about how to get through Christmas whilst …
Coping with cancer at Christmas
It’s November and already that time of year again when the Christmas adverts appear on TV and the shops are …
Binimetinib in low-grade serous carcinoma
A phase II study of Selumetinib, an oral small-molecule inhibitor of MEK1/2, has shown promising results in patients with recurrent …
Giving CuresDay on Giving Tuesday
Cure Our Ovarian Cancer is Celebrating GivingTuesday in Europe with #GivingCuresDay joining millions around the world participating in the global …
World Hospice and Palliative Care Day
On Saturday 12 October, people across the world will be celebrating and supporting hospice and palliative care. As World Hospice …
Study Shows Trametinib Improves Outcomes for Women with Low-Grade Serous Carcinoma of the Ovary/Peritoneum on NRG Oncology Trial
Results from GOG 0281, a randomised phase II/III clinical trial, were presented by Dr Gershenson on Sunday at the European …
World Ovarian Cancer Day
What is World Ovarian Cancer Day May 8th is World Ovarian Cancer Day – an initiative of the World Ovarian …
#OneHellOvaWoman
It is with a very heavy heart that we received the news that Elly Mayday passed away on the 1st …
The Five Easiest Fundraisers
Have you created a fundraiser yet? Here are five easy ideas to get you started. Use an existing event. For …
- Page 1 of 2
- 1
- 2